CN EN
About us
Who We Are
A stellar compliance record following global standards

BioDuro-Sundia, an Advent International portfolio company is a trusted, leading contract research, development, and manufacturing organization (CRDMO) for over 28 years. We provide our biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification to commercial drug product manufacturing. The company is based in the US and China with nearly 3,000 employees and 7 global sites across 6 cities.

Core expertise includes small and large molecule discovery, development and scale-up, support for IND submission, and unique technology platforms such as bioavailability enhancement of insoluble compounds. The one-stop shop operation helps biotech and pharma partners across the globe to significantly accelerate discovery and de-risk development to create higher value outcomes. We adhere to one global highest standard of compliance and business operation code. Science-driven, customer-oriented, flexible, people-focused culture enables us to provide top-tier integrated, fast and flexible tailored services to our customers to meet their unique needs and accelerate development timelines.

28
Years
Since Operation
~2,300
Active Projects
~3,000
Staff Worldwide
1,500
+
Active Customers
7
Facilities Across 6
Cities Globally
Our Mission
To be the TRUSTED partner delivering world-class drug discovery,
development and manufacturing services
CORPORATE VALUES: ARTRI
ACCOUNTABILITY
We always take responsibility for our actions and behavior and conduct ourselves to established metrics of high performance.
RESPECT
We deeply respect our employees and clients, within a family structure, based on equality and understanding.
TENACITY
We know we may face adversity, but will never give up, but persevere to succeed.
RESULTS
We establish clear measures of success and deliver results to our internal and external stakeholders.
INTEGRITY
We are honest with ourselves and transparent in our actions and hold Intellectual Property (IP) standards at the highest level.
Global Presence
With focused centers of excellence in the
United States and China
Learn more
Our History
We went through multiple successful integrations and have embarked on the next phase of growth to deliver more value to customers
2021

Acquired two US-based commercial drug product manufacturing facilities with over 100,000 sq. ft. and 4 billion doses capacity annually

Completed 1st GMP drug product manufacturing at new R&D center in Wuxi

2020

Acquired Sundia to become BioDuro-Sundia, one of the largest CRDMOs worldwide

300,000 sq. ft. Wuxi facility opened with integrated capabilities across discovery and GMP manufacturing

2019

Advent bought majority of stake and partnered with BioDuro

2018

Acquired Molecular Response (“Tumor Bank”)

2015

BioDuro reacquired from PPD; BioDuro and Formex merged to enable broad range of service offering

2013

Formex joined Bridgewest Group, operating in a 44,000 sq. ft. GMP facility

2012

93,000 sq. ft. Shanghai facility (72,000 sq. ft. lab) opened to meet growing client demand

2009

BioDuro acquired by PPD

2007

Sundia merged with United Pharma

2006

100,000 sq. ft. Beijing site opened –first site in China

2005

BioDuro founded in San Diego by Biotech Investment Group with operations commenced in Beijing

2004

Sundia founded

1996

Formex formed

Business Ethics
Business Conduct and Ethics

At BioDuro-Sundia, we operate with integrity and strict standards of law and business ethics, which are our fundamental guidelines in all locations. We adhere to the business ethics of legal compliance, integrity, and self-discipline, and always strictly comply with laws and regulations related to corporate governance and the Corporate Governance Code with zero tolerance for any form of corruption. We have built a strong security infrastructure that protects and preserves the intellectual property and data of our customers; We are implementing green manufacturing and sustainable operations across our business units, helping to improve the environment and our communities.

Learn more
Large Molecule Bioanalysis Services
BioDuro-Sundia’s large molecule bioanalysis DMPK/ADME platform provides representative research services to a variety of molecular modalities including mAbs, ADC, oligonucleotides, large or small molecule biomarkers or metabolites, proteins and peptides.
View more
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all